374 related articles for article (PubMed ID: 15583748)
21. Effect of antithrombin III on glycoprotein Ib/IX/V activation in human platelets: suppression of thromboxane A2 generation.
Doi T; Tokuda H; Matsushima-Nishiwaki R; Cuong NT; Kageyama Y; Iida Y; Kondo A; Akamatsu S; Otsuka T; Iida H; Kozawa O; Ogura S
Prostaglandins Leukot Essent Fatty Acids; 2012; 87(2-3):57-62. PubMed ID: 22819492
[TBL] [Abstract][Full Text] [Related]
22. Arsenic trioxide-mediated antiplatelet activity: pivotal role of the phospholipase C gamma 2-protein kinase C-p38 MAPK cascade.
Lin KH; Chang YF; Fan CY; Jayakumar T; Lee JJ; Chou DS; Hsiao G; Sheu JR
Transl Res; 2010 Feb; 155(2):97-108. PubMed ID: 20129490
[TBL] [Abstract][Full Text] [Related]
23. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets.
Minuz P; Fumagalli L; Gaino S; Tommasoli RM; Degan M; Cavallini C; Lecchi A; Cattaneo M; Lechi Santonastaso C; Berton G
Biochem J; 2006 Nov; 400(1):127-34. PubMed ID: 16859489
[TBL] [Abstract][Full Text] [Related]
24. Cyclic nucleotides inhibit MAP kinase activity in low-dose collagen-stimulated platelets.
Jackson EC; McNicol A
Thromb Res; 2010 Feb; 125(2):147-51. PubMed ID: 19595442
[TBL] [Abstract][Full Text] [Related]
25. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
[TBL] [Abstract][Full Text] [Related]
26. Platelet 12-lipoxygenase activation via glycoprotein VI: involvement of multiple signaling pathways in agonist control of H(P)ETE synthesis.
Coffey MJ; Jarvis GE; Gibbins JM; Coles B; Barrett NE; Wylie OR; O'Donnell VB
Circ Res; 2004 Jun; 94(12):1598-605. PubMed ID: 15142951
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation.
Quinton TM; Kim S; Dangelmaier C; Dorsam RT; Jin J; Daniel JL; Kunapuli SP
Biochem J; 2002 Dec; 368(Pt 2):535-43. PubMed ID: 12215172
[TBL] [Abstract][Full Text] [Related]
28. YD-3, a novel inhibitor of protease-induced platelet activation.
Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP.
Shen MY; Hsiao G; Liu CL; Fong TH; Lin KH; Chou DS; Sheu JR
Br J Haematol; 2007 Nov; 139(3):475-85. PubMed ID: 17868048
[TBL] [Abstract][Full Text] [Related]
30. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Res; 1999 Sep; 95(6):315-23. PubMed ID: 10527409
[TBL] [Abstract][Full Text] [Related]
31. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation.
Werner MH; Senzel L; Bielawska A; Khan W; Hannun YA
Mol Pharmacol; 1991 Apr; 39(4):547-56. PubMed ID: 2017154
[TBL] [Abstract][Full Text] [Related]
32. Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets.
Chen WF; Lee JJ; Chang CC; Lin KH; Wang SH; Sheu JR
Haematologica; 2013 May; 98(5):793-801. PubMed ID: 23065519
[TBL] [Abstract][Full Text] [Related]
33. Involvement of Rac in thromboxane A2‑induced human platelet activation: regulation of sCD40 ligand release and PDGF‑AB secretion.
Kageyama Y; Doi T; Matsushima-Nishiwaki R; Iida Y; Akamatsu S; Kondo A; Kuroyanagi G; Yamamoto N; Mizutani J; Otsuka T; Tokuda H; Iida H; Kozawa O; Ogura S
Mol Med Rep; 2014 Jul; 10(1):107-12. PubMed ID: 24737161
[TBL] [Abstract][Full Text] [Related]
34. Platelet activation by Streptococcus sanguinis is accompanied by MAP kinase phosphorylation.
Abdulrehman AY; Jackson EC; McNicol A
Platelets; 2013; 24(1):6-14. PubMed ID: 22372533
[TBL] [Abstract][Full Text] [Related]
35. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase.
Chang CC; Lu WJ; Chiang CW; Jayakumar T; Ong ET; Hsiao G; Fong TH; Chou DS; Sheu JR
J Nutr Biochem; 2010 Dec; 21(12):1214-21. PubMed ID: 20015631
[TBL] [Abstract][Full Text] [Related]
36. Evidence for a role for phospholipase C, but not phospholipase A2, in platelet activation in response to low concentrations of collagen.
Lockhart LK; Pampolina C; Nickolaychuk BR; McNicol A
Thromb Haemost; 2001 May; 85(5):882-9. PubMed ID: 11372683
[TBL] [Abstract][Full Text] [Related]
37. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of the MEK/ERK pathway has no effect on agonist-induced aggregation of human platelets.
McNicol A; Jackson EC
Biochem Pharmacol; 2003 Apr; 65(8):1243-50. PubMed ID: 12694865
[TBL] [Abstract][Full Text] [Related]
39. P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation.
Shankar H; Garcia A; Prabhakar J; Kim S; Kunapuli SP
J Thromb Haemost; 2006 Mar; 4(3):638-47. PubMed ID: 16460446
[TBL] [Abstract][Full Text] [Related]
40. Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin.
Vega-Ostertag M; Harris EN; Pierangeli SS
Arthritis Rheum; 2004 Sep; 50(9):2911-9. PubMed ID: 15457460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
